/i.s3.glbimg.com/v1/AUTH_da025474c0c44edd99332dddb09cabe8/internal_photos/bs/2023/1/X/nkkB7tSdirnIUbGhakCQ/favicon-o-globo.png){kind=small}
/i.s3.glbimg.com/v1/AUTH_59edd422c0c84a879bd37670ae4f538a/internal_photos/bs/2021/H/w/YbA657S3aYVfC0P9wboQ/g1-favicon.png){kind=small}
Overview
- Tatiana Schlossberg, 35, publicly shared her diagnosis in a first‑person piece published November 22.
- She learned of the illness shortly after delivering her second child in May 2024 following alarming postpartum bloodwork.
- Her white blood cell count measured 131,000 per microliter, far above a typical range of about 4,000 to 11,000.
- She says treatment has included multiple chemotherapy rounds, two bone marrow transplants, and participation in two clinical trials.
- She reports an inversion 3 AML mutation found in fewer than 2% of cases, and coverage on November 24 amplified details from her essay.